Extracellular Domains of CD8α and CD8ß Subunits Are Sufficient for HLA Class I Restricted Helper Functions of TCR-Engineered CD4+ T Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  van Loenen, Marleen M ^a   Hagedoorn, Renate S ^a   de Boer, Renate ^a   Falkenburg, J H Frederik ^a   Heemskerk, Mirjam H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CD8ALPHA ANTIGEN; CD8BETA ANTIGEN; CELL ADHESION MOLECULE; HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ENGINEERING; CONTROLLED STUDY; GENETIC TRANSDUCTION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOCYTE FUNCTION; PROTEIN DOMAIN; PROTEIN SUBUNIT;

ANTIGENS, CD8; CD4-POSITIVE T-LYMPHOCYTES; CELL ENGINEERING; EXTRACELLULAR SPACE; HLA ANTIGENS; HUMANS; INTERFERON-GAMMA; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFECTION;

EID: 84878510652     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065212     Document Type: Article

References (46)

1. Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, et al. (2008) Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 26: 5233-5239.
2. Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, et al. (1997) Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 15: 433-444.
3. Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, et al. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76: 2462-2465.
4. Porter DL, Collins RH Jr, Hardy C, Kernan NA, Drobyski WR, et al. (2000) Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 95: 1214-1221.
5. Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, et al. (1999) Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J Immunol 163: 507-513.
6. Cooper LJ, Kalos M, Lewinsohn DA, Riddell SR, Greenberg PD, (2000) Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J Virol 74: 8207-8212.
7. Dembic Z, Haas W, Weiss S, McCubrey J, Kiefer H, et al. (1986) Transfer of specificity by murine alpha and beta T-cell receptor genes. Nature 320: 232-238.
8. Heemskerk MH, Hoogeboom M, de Paus RA, Kester MG, van der Hoorn MA, et al. (2003) Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood 102: 3530-3540.
9. Heemskerk MH, Hoogeboom M, Hagedoorn R, Kester MG, Willemze R, et al. (2004) Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer. J Exp Med 199: 885-894.
10. Kessels HW, Wolkers MC, van den Boom MD, van der Valk MA, Schumacher TN, (2001) Immunotherapy through TCR gene transfer. Nat Immunol 2: 957-961.
11. Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, et al. (2009) Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114: 535-546.
12. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, et al. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
13. Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, et al. (2011) Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol 29: 917-924.
14. McKinney DM, Lewinsohn DA, Riddell SR, Greenberg PD, Mosier DE, (1999) The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. J Immunol 163: 861-867.
15. Ahmed R, Gray D, (1996) Immunological memory and protective immunity: understanding their relation. Science 272: 54-60.
16. Kessels HW, Schepers K, van den Boom MD, Topham DJ, Schumacher TN, (2006) Generation of T cell help through a MHC class I-restricted TCR. J Immunol 177: 976-982.
17. McNicol AM, Bendle G, Holler A, Matjeka T, Dalton E, et al. (2007) CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR. Eur J Immunol 37: 1634-1641.
18. Baume DM, Caligiuri MA, Manley TJ, Daley JF, Ritz J, (1990) Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell Immunol 131: 352-365.
19. Goodman T, Lefrancois L, (1988) Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature 333: 855-858.
20. Guy-Grand D, Cerf-Bensussan N, Malissen B, Malassis-Seris M, Briottet C, et al. (1991) Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J Exp Med 173: 471-481.
21. Janeway CA Jr, (1992) The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 10: 645-674.
22. Rocha B, Vassalli P, Guy-Grand D, (1991) The V beta repertoire of mouse gut homodimeric alpha CD8+ intraepithelial T cell receptor alpha/beta + lymphocytes reveals a major extrathymic pathway of T cell differentiation. J Exp Med 173: 483-486.
23. Zamoyska R, (1994) The CD8 coreceptor revisited: one chain good, two chains better. Immunity 1: 243-246.
24. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, et al. (1990) A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 345: 41-46.
25. Barber EK, Dasgupta JD, Schlossman SF, Trevillyan JM, Rudd CE, (1989) The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci U S A 86: 3277-3281.
26. Turner JM, Brodsky MH, Irving BA, Levin SD, Perlmutter RM, et al. (1990) Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60: 755-765.
27. Veillette A, Bookman MA, Horak EM, Bolen JB, (1988) The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55: 301-308.
28. Veillette A, Zuniga-Pflucker JC, Bolen JB, Kruisbeek AM, (1989) Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J Exp Med 170: 1671-1680.
29. Arcaro A, Gregoire C, Bakker TR, Baldi L, Jordan M, et al. (2001) CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J Exp Med 194: 1485-1495.
30. Irie HY, Ravichandran KS, Burakoff SJ, (1995) CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity. J Exp Med 181: 1267-1273.
31. Bosselut R, Zhang W, Ashe JM, Kopacz JL, Samelson LE, et al. (1999) Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction. J Exp Med 190: 1517-1526.
32. Bosselut R, Kubo S, Guinter T, Kopacz JL, Altman JD, et al. (2000) Role of CD8beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus. Immunity 12: 409-418.
33. Renard V, Romero P, Vivier E, Malissen B, Luescher IF, (1996) CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding. J Exp Med 184: 2439-2444.
34. Witte T, Spoerl R, Chang HC, (1999) The CD8beta ectodomain contributes to the augmented coreceptor function of CD8alphabeta heterodimers relative to CD8alphaalpha homodimers. Cell Immunol 191: 90-96.
35. Fung-Leung WP, Louie MC, Limmer A, Ohashi PS, Ngo K, et al. (1993) The lack of CD8 alpha cytoplasmic domain resulted in a dramatic decrease in efficiency in thymic maturation but only a moderate reduction in cytotoxic function of CD8+ T lymphocytes. Eur J Immunol 23: 2834-2840.
36. Itano A, Cado D, Chan FK, Robey E, (1994) A role for the cytoplasmic tail of the beta chain of CD8 in thymic selection. Immunity 1: 287-290.
37. Scholten KB, Kramer D, Kueter EW, Graf M, Schoedl T, et al. (2006) Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells. Clin Immunol 119: 135-145.
38. Boulter JM, Glick M, Todorov PT, Baston E, Sami M, et al. (2003) Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng 16: 707-711.
39. Kuball J, Dossett ML, Wolfl M, Ho WY, Voss RH, et al. (2007) Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood 109: 2331-2338.
40. van Loenen MM, de Boer R, Hagedoorn RS, van Egmond EH, Falkenburg JH, et al. (2011) Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies. Haematologica 96: 477-481.
41. Amir AL, van der Steen DM, van Loenen MM, Hagedoorn RS, de Boer R, et al. (2011) PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer. Clin Cancer Res 17: 5615-5625.
42. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, et al. (2004) Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol 22: 589-594.
43. Burrows SR, Kienzle N, Winterhalter A, Bharadwaj M, Altman JD, et al. (2000) Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J Immunol 165: 6229-6234.
44. Zandvliet ML, van LE, Jedema I, Kruithof S, Kester MG, et al. (2011) Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation. J Immunother 34: 307-319.
45. Heemskerk MH, Hagedoorn RS, van der Hoorn MA, van der Veken LT, Hoogeboom M, et al. (2007) Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 109: 235-243.
46. van Loenen MM, Hagedoorn RS, Kester MG, Hoogeboom M, Willemze R, et al. (2009) Kinetic preservation of dual specificity of coprogrammed minor histocompatibility antigen-reactive virus-specific T cells. Cancer Res 69: 2034-2041.